Bank of New York Mellon’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-26,220
Closed -$267K 4202
2025
Q1
$267K Sell
26,220
-1,134
-4% -$11.6K ﹤0.01% 3736
2024
Q4
$382K Hold
27,354
﹤0.01% 3639
2024
Q3
$533K Sell
27,354
-9,415
-26% -$184K ﹤0.01% 3477
2024
Q2
$684K Buy
36,769
+35,511
+2,823% +$661K ﹤0.01% 3388
2024
Q1
$17.6K Sell
1,258
-4,435
-78% -$62.2K ﹤0.01% 4106
2023
Q4
$48.3K Sell
5,693
-191
-3% -$1.62K ﹤0.01% 4153
2023
Q3
$52.6K Sell
5,884
-2,529
-30% -$22.6K ﹤0.01% 4150
2023
Q2
$72.6K Sell
8,413
-98,001
-92% -$846K ﹤0.01% 4111
2023
Q1
$1.12M Sell
106,414
-2,346
-2% -$24.7K ﹤0.01% 3083
2022
Q4
$3.69M Sell
108,760
-5,872
-5% -$199K ﹤0.01% 2513
2022
Q3
$5.5M Buy
114,632
+2,021
+2% +$97K ﹤0.01% 2244
2022
Q2
$6.42M Sell
112,611
-6,772
-6% -$386K ﹤0.01% 2183
2022
Q1
$9.65M Buy
119,383
+5,870
+5% +$475K ﹤0.01% 2084
2021
Q4
$23M Sell
113,513
-1,046
-0.9% -$212K ﹤0.01% 1642
2021
Q3
$30.9M Sell
114,559
-688
-0.6% -$185K 0.01% 1458
2021
Q2
$29.7M Buy
115,247
+443
+0.4% +$114K 0.01% 1504
2021
Q1
$34.4M Sell
114,804
-734
-0.6% -$220K 0.01% 1367
2020
Q4
$29.5M Sell
115,538
-3,942
-3% -$1.01M 0.01% 1392
2020
Q3
$29.7M Sell
119,480
-4,382
-4% -$1.09M 0.01% 1204
2020
Q2
$43M Buy
123,862
+3,831
+3% +$1.33M 0.01% 972
2020
Q1
$32.1M Sell
120,031
-2,055
-2% -$550K 0.01% 1001
2019
Q4
$39.5M Buy
122,086
+23,075
+23% +$7.47M 0.01% 1125
2019
Q3
$27.1M Buy
99,011
+385
+0.4% +$105K 0.01% 1341
2019
Q2
$52.6M Buy
98,626
+2,345
+2% +$1.25M 0.01% 946
2019
Q1
$48.5M Buy
96,281
+1,701
+2% +$857K 0.01% 972
2018
Q4
$46.6M Buy
94,580
+1,178
+1% +$581K 0.01% 939
2018
Q3
$85.4M Buy
93,402
+16,074
+21% +$14.7M 0.02% 694
2018
Q2
$56.6M Sell
77,328
-8,577
-10% -$6.28M 0.02% 918
2018
Q1
$137M Sell
85,905
-45,752
-35% -$72.9M 0.04% 459
2017
Q4
$118M Sell
131,657
-5,822
-4% -$5.22M 0.03% 546
2017
Q3
$49.5M Sell
137,479
-5,096
-4% -$1.83M 0.01% 996
2017
Q2
$41.8M Buy
142,575
+848
+0.6% +$249K 0.01% 1086
2017
Q1
$49.9M Buy
141,727
+11,154
+9% +$3.93M 0.01% 960
2016
Q4
$24M Buy
130,573
+8,902
+7% +$1.64M 0.01% 1422
2016
Q3
$31.4M Buy
121,671
+3,738
+3% +$963K 0.01% 1163
2016
Q2
$25.2M Sell
117,933
-9,973
-8% -$2.13M 0.01% 1259
2016
Q1
$26.4M Buy
127,906
+3,278
+3% +$676K 0.01% 1232
2015
Q4
$31.5M Buy
124,628
+5,792
+5% +$1.46M 0.01% 1091
2015
Q3
$19.5M Buy
118,836
+20,105
+20% +$3.31M 0.01% 1420
2015
Q2
$18.5M Sell
98,731
-66,230
-40% -$12.4M 0.01% 1537
2015
Q1
$27.2M Sell
164,961
-63,528
-28% -$10.5M 0.01% 1274
2014
Q4
$53.1M Sell
228,489
-8,143
-3% -$1.89M 0.01% 862
2014
Q3
$42.8M Buy
236,632
+172
+0.1% +$31.1K 0.01% 959
2014
Q2
$45.5M Buy
236,460
+3,558
+2% +$684K 0.01% 961
2014
Q1
$42.3M Buy
232,902
+8,537
+4% +$1.55M 0.01% 993
2013
Q4
$38.2M Buy
224,365
+50,828
+29% +$8.65M 0.01% 1040
2013
Q3
$27.2M Sell
173,537
-25,444
-13% -$3.99M 0.01% 1203
2013
Q2
$34.5M Buy
+198,981
New +$34.5M 0.01% 1033